# A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar

> **NCT00497601** · PHASE2 · COMPLETED · sponsor: **Banaras Hindu University** · enrollment: 60 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Amphotericin B fat emulsion in visceral leishmaniasis
- **DRUG:** Amphotericin B fat emulsion
- **DRUG:** Amphotericin B in fat emulsion

## Key facts

- **NCT ID:** NCT00497601
- **Lead sponsor:** Banaras Hindu University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497601, "A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00497601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*